TBXT and colorectal cancer: On the other hand, TFT is activated rapidly because it only needs one phosphorylation step in contrast to 5FU, and therefore TFT can be active against 5FU-resistant colorectal cancer cells (Murakami et al, 2000; Emura et al, 2004a).